3.60
6.49%
-0.25
Dopo l'orario di chiusura:
3.61
0.010
+0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$3.85
Aprire:
$3.82
Volume 24 ore:
1.65M
Relative Volume:
0.97
Capitalizzazione di mercato:
$386.70M
Reddito:
$42.51M
Utile/perdita netta:
$-116.49M
Rapporto P/E:
-2.9752
EPS:
-1.21
Flusso di cassa netto:
$-120.82M
1 W Prestazione:
+6.51%
1M Prestazione:
-51.74%
6M Prestazione:
-52.13%
1 anno Prestazione:
-52.63%
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Confronta TNGX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
TNGX | 3.60 | 386.70M | 42.51M | -116.49M | -120.82M | -1.21 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-12-08 | Iniziato | B. Riley Securities | Buy |
2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2021-09-20 | Iniziato | SVB Leerink | Outperform |
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Trv Gp Iv LLC Has $129.82 Million Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - MarketBeat
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of "Buy" from Analysts - MarketBeat
B. Riley Increases Earnings Estimates for Tango Therapeutics - Defense World
B. Riley Forecasts Higher Earnings for Tango Therapeutics - MarketBeat
B. Riley Cuts Tango Therapeutics (NASDAQ:TNGX) Price Target to $8.00 - Defense World
Tango Therapeutics' SWOT analysis: stock outlook amid PRMT5 inhibitor progress - Investing.com
Tango Therapeutics (NASDAQ:TNGX) Earns “Buy” Rating from HC Wainwright - Defense World
The Analyst Landscape: 5 Takes On Tango Therapeutics - Benzinga
B. Riley Has Lowered Expectations for Tango Therapeutics (NASDAQ:TNGX) Stock Price - MarketBeat
FY2024 Earnings Forecast for TNGX Issued By Leerink Partnrs - Defense World
Leerink Partnrs Brokers Increase Earnings Estimates for TNGX - MarketBeat
EcoR1 Capital sells $8.4 million in Tango Therapeutics stock - Investing.com India
EcoR1 Capital sells $8.4 million in Tango Therapeutics stock By Investing.com - Investing.com Australia
Tango Therapeutics' (TNGX) Buy Rating Reiterated at HC Wainwright - MarketBeat
Wedbush Has Pessimistic Outlook of TNGX FY2024 Earnings - Defense World
EcoR1 Capital, LLC Adjusts Stake in Tango Therapeutics Inc - GuruFocus.com
Wedbush Forecasts Reduced Earnings for Tango Therapeutics - MarketBeat
Tango Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Tango Therapeutics sees $9.67m stock sale by Boxer Capital - Investing.com India
Tango Therapeutics (NASDAQ:TNGX) Price Target Lowered to $8.00 at Guggenheim - MarketBeat
Tango Therapeutics Advances Cancer Treatment Pipeline - TipRanks
Two to Tango: Brain cancer drugs go further into development - BioWorld Online
Tango stock plunges 28% amid pipeline updates, Q3 earnings report (NASDAQ:TNGX) - Seeking Alpha
U.S. Stock market: Sunnova energy(-42.35%0, Zoomcar(-38.48%), Tango therapeutics(-27.22%) among stock losers during early trading - Business Upturn
Tango Shares Plunge After 3Q Loss, Product Plans - MarketWatch
Tango Therapeutics advances cancer drug into full development By Investing.com - Investing.com Canada
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program - BioSpace
Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Tango Therapeutics advances cancer drug into full development - Investing.com
Tango Therapeutics Reports 43% Response Rate in Cancer Trial, Secures $293M Cash Runway | TNGX Stock News - StockTitan
Tango's TNG462 Cancer Drug Shows Promise; New Brain-Penetrant Treatment Unveiled | TNGX Stock News - StockTitan
Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week LowTime to Sell? - MarketBeat
Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - Simply Wall St
Tango Therapeutics (NASDAQ:TNGX) Stock Rating Reaffirmed by HC Wainwright - Defense World
Tango Therapeutics (NASDAQ:TNGX) Sets New 12-Month Low After Insider Selling - Defense World
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month Low Following Insider Selling - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tango Therapeutics target held at $13 by H.C. Wainwright - Investing.com
Tango Therapeutics (NASDAQ:TNGX) Sees Strong Trading VolumeHere's Why - MarketBeat
Short Interest in Tango Therapeutics, Inc. (NASDAQ:TNGX) Decreases By 17.7% - MarketBeat
Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells $4,348,710.00 in Stock - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Receives Buy Rating from HC Wainwright - MarketBeat
Tango Therapeutics sees $4.3 million stock sale by Boxer Capital - Investing.com Australia
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 8.7%Time to Buy? - MarketBeat
Tango Therapeutics sees $6.1 million stock sale by Boxer Capital - Investing.com Australia
(TNGX) Proactive Strategies - Stock Traders Daily
Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Boxer Capital Management, Llc Sells 625,000 Shares - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Hits New 1-Year LowHere's What Happened - MarketBeat
Tango Therapeutics Inc (TNGX) Stock Price & Chart | Trade Now - Capital.com
Ares Management Co. (NYSE:ARES) Shares Acquired by Vontobel Holding Ltd. - Defense World
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):